Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4064)
All Articles published online
|
Dec 7, 2012 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yi W, Liu M, Cai HD. Safety of lamivudine treatment for chronic hepatitis B in early pregnancy. World J Gastroenterol 2012; 18(45): 6645-6650 [PMID: 23236240 DOI: 10.3748/wjg.v18.i45.6645] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i45/6645.htm |
| Number | Citing Articles |
| 1 |
Wolfram H. Gerlich. Reduction of Infectivity in Chronic Hepatitis B Virus Carriers among Healthcare Providers and Pregnant Women by Antiviral Therapy. Intervirology 2014; 57(3-4): 202 doi: 10.1159/000360949
|
| 2 |
Isobel D. Ramsay, Jodi M. Lestner, Catherine P. O’Sullivan, Ana L.G. Cruz, Ho Kwong Li, Charlotte I.S. Barker. A worldwide yearly survey of new data in adverse drug reactions. Side Effects of Drugs Annual 2014; 36: 401 doi: 10.1016/B978-0-444-63407-8.00029-0
|
| 3 |
Lung-Yi Mak, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen. DNA polymerase inhibitors for treating hepatitis B: a safety evaluation. Expert Opinion on Drug Safety 2016; 15(3): 383 doi: 10.1517/14740338.2016.1139573
|
| 4 |
Emanuela Zappulo, Agnese Giaccone, Nicola Schiano Moriello, Ivan Gentile. Pharmacological approaches to prevent vertical transmission of HIV and HBV. Expert Review of Clinical Pharmacology 2022; 15(7): 863 doi: 10.1080/17512433.2022.2105202
|
| 5 |
M. J. Tong, C. Q. Pan, S.‐H. B. Han, D. S.‐K. Lu, S. Raman, K.‐Q. Hu, J. K. Lim, H. W. Hann, A. D. Min. An expert consensus for the management of chronic hepatitis B in Asian Americans. Alimentary Pharmacology & Therapeutics 2018; 47(8): 1181 doi: 10.1111/apt.14577
|
| 6 |
Marilza V.C. Rudge, Fernanda C.B. Alves, Raghavendra L.S. Hallur, Rafael G. Oliveira, Sofia Vega, David R.A. Reyes, Juliana F. Floriano, Caroline B. Prudencio, Gabriela A. Garcia, Fabiana V.D.S. Reis, Costanza Emanueli, Gonzalo Fuentes, Marcelo Cornejo, Fernando Toledo, Andrés Valenzuela-Hinrichsen, Catalina Guerra, Adriana Grismaldo, Paola Valero, Angelica M.P. Barbosa, Luis Sobrevia. Consequences of the exposome to gestational diabetes mellitus. Biochimica et Biophysica Acta (BBA) - General Subjects 2023; 1867(2): 130282 doi: 10.1016/j.bbagen.2022.130282
|
| 7 |
Wenjun Wang, Jingjing Wang, Shuangsuo Dang, Guihua Zhuang. Cost-effectiveness of antiviral therapy during late pregnancy to prevent perinatal transmission of hepatitis B virus. PeerJ 2016; 4: e1709 doi: 10.7717/peerj.1709
|
| 8 |
Yu-Hong Hu, Min Liu, Wei Yi, Yan-Jun Cao, Hao-Dong Cai. Tenofovir rescue therapy in pregnant females with chronic hepatitis B. World Journal of Gastroenterology 2015; 21(8): 2504-2509 doi: 10.3748/wjg.v21.i8.2504
|
| 9 |
Zhenhua Li, Baojiang Xie, Nuo Yi, Haodong Cai, Wei Yi, Xuesong Gao. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology 2022; 276: 102 doi: 10.1016/j.ejogrb.2022.07.009
|
| 10 |
Frank Wong, Rohit Pai, Julie Van Schalkwyk, Eric M. Yoshida. Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis. Annals of Hepatology 2014; 13(2): 187 doi: 10.1016/S1665-2681(19)30881-6
|
| 11 |
Xuesong Gao, Xuefei Duan, Haodong Cai, Yuhong Hu, Min Liu, Kai Kang, Mingfang Zhou, Dong Fu, Wei Yi. Pregnancy outcomes for pregnant women with chronic hepatitis B exposing to entecavir or adefovir dipivoxil therapy before or in early pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine 2022; 35(3): 476 doi: 10.1080/14767058.2020.1723540
|
| 12 |
Bengt Källén. Maternal Drug Use and Infant Congenital Malformations. 2019; : 181 doi: 10.1007/978-3-030-17898-7_16
|
| 13 |
Lu Zhang, Tingting Jiang, Ying Yang, Wen Deng, Huihui Lu, Shiyu Wang, Ruyu Liu, Min Chang, Shuling Wu, Yuanjiao Gao, Hongxiao Hao, Ge Shen, Mengjiao Xu, Xiaoxue Chen, Leiping Hu, Liu Yang, Xiaoyue Bi, Yanjie Lin, Yao Lu, Yuyong Jiang, Minghui Li, Yao Xie. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection. Frontiers in Immunology 2023; 13 doi: 10.3389/fimmu.2022.1112234
|
| 14 |
Hanan M. Foaud, Sahar Maklad, Amany Gmal El Din, Faten Mahmoud. Lamivudine use in pregnant HBsAg-females effectively reduces maternal viremia. Arab Journal of Gastroenterology 2019; 20(1): 8 doi: 10.1016/j.ajg.2019.02.003
|
| 15 |
Y. Hu, C. Xu, B. Xu, L. Hu, Q. Liu, J. Chen, J. Liu, L. Liu, J. Yang, T. Chen, J. Wen, N. Jiang, Y. Zhang, M. Cao, J. Feng, X. Lin, Z. Wang, B. Xu, Y. ‐H. Zhou. Safety and efficacy of telbivudine in late pregnancy to prevent mother‐to‐child transmission of hepatitis B virus: A multicenter prospective cohort study. Journal of Viral Hepatitis 2018; 25(4): 429 doi: 10.1111/jvh.12834
|
| 16 |
Zhenhua Li, Xuefei Duan, Yuhong Hu, Mingfang Zhou, Min Liu, Kai Kang, Haodong Cai, Wei Yi, Dong Fu, Xuesong Gao. Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1374276
|
| 17 |
Min-Min Yu, Qian Jiang, Ying Ji, Kai-Hua Wu, Li-Li Ju, Xun Tang, Yong-Feng Yang. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus. Journal of Clinical Virology 2014; 61(1): 55 doi: 10.1016/j.jcv.2014.06.005
|
| 18 |
HBV Perinatal Transmission. International Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/875791
|
| 19 |
Philip Webster, Liz Lightstone, Dianne B. McKay, Michelle A. Josephson. Pregnancy in chronic kidney disease and kidney transplantation. Kidney International 2017; 91(5): 1047 doi: 10.1016/j.kint.2016.10.045
|
| 20 |
Andrew B. Mendlowitz, Jordan J. Feld, Mia J. Biondi. Hepatitis B and C in Pregnancy and Children: A Canadian Perspective. Viruses 2022; 15(1): 91 doi: 10.3390/v15010091
|
| 21 |
Xuesong Gao, Xuefei Duan, Haodong Cai, Yuhong Hu, Min Liu, Kai Kang, Mingfang Zhou, Dong Fu, Wei Yi. The safety and efficacy of tenofovir disoproxil fumarate used throughout pregnancy for mothers with chronic hepatitis B. European Journal of Gastroenterology & Hepatology 2020; 32(12): 1533 doi: 10.1097/MEG.0000000000001662
|
| 22 |
Yingxia Liu, Miao Wang, Simin Yao, Jing Yuan, Jian Lu, Huijuan Li, Wen Zeng, Yong Deng, Rongrong Zou, Jie Li, Jia Xiao. Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of hepatitis B virus. Hepatology Research 2016; 46(3) doi: 10.1111/hepr.12525
|
| 23 |
Jinfeng Liu, Yuling Feng, Jing Wang, Xuelan Li, Chunmei Lei, Dongfang Jin, Weihong Feng, Yuan Yang, Yingli He, Yuanyuan Li, Dan Du, Xuebin Zhang, Li Jin, Taotao Yan, Tianyan Chen, Yingren Zhao. An “immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother. Human Vaccines & Immunotherapeutics 2015; 11(8): 2068 doi: 10.1080/21645515.2015.1010890
|
| 24 |
Jing Xu, Lin lin Tao, Li xian Ma. Efficacy and safety of telbivudine to prevent mother‐to‐child transmission of hepatitis B virus in middle‐ and late‐stage pregnancy with high viral loads. Journal of Medical Virology 2019; 91(12): 2153 doi: 10.1002/jmv.25566
|